HCP segmentation that sends reps to the prescribers who will move.

HCP segmentation is the grouping of healthcare professionals (HCPs), institutions and accounts into segments that share the traits that decide their value to a brand. In pharma, an HCP audience is the physicians and accounts a brand targets, and opportunity-based segmentation ranks them on four measures (patient potential, influence, prescribing behavior and access) instead of past prescription volume alone. Nextyn builds the segments from interviews and surveys with the prescribers and account decision-makers in each target market.

A Nextyn HCP segmentation delivers three outputs: segment profiles, a ranking of target HCPs and accounts by opportunity, and targeting and territory priorities for the field. Each output rests on primary interviews and surveys with prescribers and account decision-makers, not on prescription volume alone:

• Segment profiles: HCP profiling of each group on patient potential, influence, prescribing behavior and access
• Opportunity ranking: target HCPs and accounts ordered by the growth each can deliver
• Targeting and territory priorities: where field effort, call frequency and account plans should go first

Nextyn interviews and surveys the four groups that decide where a brand's growth sits: prescribing physicians, key opinion leaders, hospital and account decision-makers, and payers. The sample is matched to the therapy area and the markets where targeting decisions are being made:

• Prescribing HCPs, by specialty, practice setting and patient volume
• Key opinion leaders and senior physicians whose choices shape their peers
• Hospital, clinic and network decision-makers who control account access
• Payers and formulary decision-makers who set access conditions

Nextyn runs HCP segmentation research in the United States, Canada, the United Kingdom, Germany, France, Italy and Spain, among other markets. Markets and specialties are agreed at scoping, around the territories and accounts where the brand's field targeting decisions are being made. Recent Nextyn work includes a survey of 80 pathology and laboratory decision-makers across the USA, UK and EMEA that sharpened account priorities by region, and care-model research with specialists and nurses in Canada.

Nextyn recommends HCP segmentation before territories, call plans and account plans are set for a launch or a new planning year. Segments built at that point decide where reps go from the first call and anchor the HCP marketing strategy, instead of correcting a call list after months of effort. There are three other triggers for a fresh segmentation: a new indication, a shift in access that changes which accounts matter, and a field force that is growing or shrinking.

A Nextyn HCP segmentation project runs in four steps, from brief to read-out, and nothing is commissioned until the client approves the plan. The client sees the sample, method and price before any fieldwork, and reads every interview with the Nextyn team at the end.

1. Submit the brief: the brand, the specialties, the markets and the targeting decisions the segments must inform.
2. Receive a plan within 48 hours: who Nextyn will interview, how, and what the work costs.
3. Approve the plan: fieldwork starts only after sign-off.
4. Review the read-out: every interview read together, showing where stakeholders agree, where they conflict and what is still open.

Nextyn sends a research plan within 48 hours of receiving the brief, stating who will be interviewed, how, and what the work costs. The plan sets the fieldwork length for the specialties and markets in scope, so a single-specialty US segmentation and a multi-country account study each get their own timeline. Nothing is commissioned until the client approves that plan and its price.

Nextyn's HCP segmentation ranks prescribers and accounts by the growth each can still deliver, while decile targeting ranks them by how much they prescribed in the past. Deciles show where volume already sits, and segmentation adds influence, behavior and access to find the doctors whose prescribing can still change.